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ABSTRACT 
THE EFFECT OF TRANSCUTANEOUS NERVE NEUROSTIMULATION ON  
BLOOD FLOW AND ISCHEMIC PAIN  
Stacey Fishman 
 
Chronic pain caused by lack of blood flow is known as ischemic pain. Neurostimulation, the 
application of electrical currents through a region of the body, is effective for pain modulation, 
and it is hypothesized that this can be explained by the gate control theory and alterations of the 
sympathetic output initiated by the metaboreflex. The decrease of sympathetic output reduces 
vasoconstriction and improves blood flow. Transcutaneous electrical nerve stimulation (TENS) 
and interferential currents (IFC) stimulation, both non-invasive neurostimulation techniques, 
were evaluated for their effects on cutaneous blood flow on the palm. High or low frequency 
TENS and/or IFC, and the electrode positions (on the forearm or the back) were evaluated. 
Ischemia was induced to simulate the chronic pain experienced by individuals, and along with 
pain and blood flow, the amount of time to stabilize blood flow, known as reperfusion time, was 
investigated. There were no differences from control except for reperfusion time in IFC on the 
back. This pre-pilot study was limited by sample size, therefore future work with a larger test 
group will improve the reliability of the data and allow for the evaluation of the effects on blood 
flow and ischemic pain. 
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CHAPTER 1: INTRODUCTION 
Peripheral artery disease (PAD) is a condition in which there is limited blood flow to the 
extremities. Many individuals with PAD experience pain even when resting, an advanced 
condition known as critical limb ischemia. Ischemia occurs when there is insufficient blood flow 
and cells use anaerobic metabolism to produce energy and perform their normal functions. This 
process produces lactic acid as a byproduct and aggravates the body’s chemoreceptors, initiating 
pain [1]. Current therapies are targeted toward improving blood flow, but there are few strategies 
to reduce pain. This study aims to investigate the efficacy of a therapy which utilizes 
transcutaneous nerve stimulation (TENS) or interferential current (IFC) stimulation in order to 
increase blood flow in the region of the pain.  
1.1 Peripheral Artery Disease and Atherosclerosis 
 
According to the CDC, about 5% of 
individuals between the ages of 60 and 69 and 
over 20% of individuals over the age of 80 
have PAD [2]. The risk factors for PAD 
include advanced age, high BMI, smoking, 
hypertension, and hypercholesteremia. It 
mainly affects the arteries in the lower 
extremities, and is caused by atherosclerosis, 
as seen in Figure 1 [3]. Intimal thickening is  
caused by the proliferation of smooth muscle  
cells, infiltration of macrophages, and the  
Figure 1.  A healthy artery compared to an 
atherosclerotic artery. The right shows a healthy 
artery in the lower leg, while the left shows an 
atherosclerotic artery. The atherosclerotic artery has 
noticeable plaque buildup and could lead to PAD 
[5]. 
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build-up of cholesterol [4]. The general mechanisms involved in atherogenesis, the development 
of atherosclerosis, are illustrated in Figure 2. Intimal thickening is activated by the binding of 
Endothelin-1 (ET-1) to its receptor on smooth muscle cells. This causes the smooth muscle cells 
to proliferate and migrate to the subendothelium under the action of platelet derived growth 
factor (PDGF). ET-1 also binds to its receptors on fibroblasts to stimulate proliferation and 
collagen production. When there are high levels of calcium and cholesterol present, plaques 
may form [6]. Long streaks of these plaques are known as lesions, and they are used to classify 
atherosclerosis. Lesions are formed by foam cells, macrophages that metabolize cholesterol, and 
are deposited in the intimal lining [4]. Macrophages become foam cells when they phagocytose 
oxidized low density lipoproteins (LDL). LDLs transport triglycerides and cholesterol 
throughout the body, and when there is an abundance of LDLs in the body, macrophages begin 
attacking them, using ROS to oxidize them. The oxidized LDLs are then phagocytosed by the 
macrophages, and the macrophages take on the appearance of being fluffy [6]. The oxidized 
LDLs are toxic to the macrophages and initiate apoptosis, or programmed cell death, which 
begins the formation of the necrotic core of the atherosclerotic plaque. Atherosclerosis is 
enhanced by inflammation. Inflammation occurs due to damage on the vessel lining, and this 
can be caused by turbulent flow from hypertension. Once there is damage to the vessel wall, 
endothelial cells, the cells lining vessels, secrete factors which promote a procoagulent state. 
During the procoagulent state, the lining expresses factors which allow immune cells such as 
macrophages and T-cells to infiltrate. T-cells produce IL-1, INF-γ, and TNF. All of these factors 
contribute to inflammation and the procoagulent state, thus continuing atherosclerosis [6]. There 
are several outcomes of atherosclerotic plaque formation.  
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Figure 2. An illustration of the process of atherogenesis. On the left, a 
monocyte/macrophage is infiltrating the intima of the artery due to the 
expression of adhesion molecules from inflammation. Foam cell formation 
can be seen as well as plaque formation due to apoptosis and collagen 
production around the necrotic core. A bulge in the intima can be seen, 
known as intimal thickening due to plaque formation [7]. 
 
The narrowing of the arteries restricts blood flow and creates flow turbulence. Turbulence in 
blood flow damages the endothelial lining of the arteries and increases the likelihood of 
thrombus formation. Thrombi have the possibility of detaching from the surface of the 
endothelial layer in the artery and embolizing. When a thrombus embolizes, it gets trapped in the 
smaller vasculature of the body, mainly in the heart causing a cardiac infarction (heart attack), or 
the brain causing an ischemic stroke.  
In addition to thrombus formation, restricted blood flow occurs as a result of the narrowing of 
the arteries. Less blood flow to limbs such as the lower extremities can cause pain due to a lack 
of oxygen and can even occur at rest [8]. Ischemic pain occurs when the muscles in the body 
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begin to use anabolic metabolism, producing lactic acid and lowering the pH of the blood. Cells 
in the body become damaged from the lack of oxygen and lowered pH and release bradykinin. 
Bradykinin is released because of its vasodilatory function, but also irritates chemoreceptors, 
amplifying pain [1].  
The majority of treatments for PAD are focused on treating the pain. Several methods include 
maintaining a healthy diet, exercising, medications to lower blood pressure and cholesterol 
levels, angioplasty, stenting, and arterial bypass grafting [8]. Many of these treatments have 
drawbacks. For example, arterial grafting requires an invasive procedure in which a portion of 
the femoral vein is removed and grafted on the occluded vessel. Grafting has also been 
performed using a synthetic material such as Dacron, but these grafts have the risk of thrombus 
formation, as does any foreign material placed in contact with blood.  Pain medication is often 
used to treat PAD. 
Pain medication, however, does not treat the underlying cause of the pain, it only masks it. Non-
steroidal anti-inflammatory drugs (NSAIDs), including aspirin and ibuprofen, are commonly 
recommended to relieve ischemic pain. NSAIDs work by inhibiting cyclooxygenase-1 and -2 
(COX), which normally oxidizes arachidonic acid into prostaglandins, decreasing inflammation. 
In addition to not improving blood flow, NSAIDs have side effects that can be harmful, such as 
increased acid production in the stomach (due to reduced prostaglandin levels), causing irritation 
and ulcers [9]. Therefore, treatments with fewer side effects are preferable.  
Neurostimulation has been investigated previously for its effects on reducing pain and improving 
blood flow and has no known side effects. Many types of neurostimulation have been tested for 
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this application including spinal cord stimulation (SCS), electroaccupuncture, interferential 
currents (IFC) stimulation, and transcutaneous electrical nerve stimulation (TENS).  
1.2 Neurostimulation Techniques 
 
SCS, which is performed by inserting epidural needles into the spinal cord, increases peripheral 
blood flow. More specifically, a lead containing between 4 to 32 electrodes is passed through the 
inner portion of the needle into the midline of the spinal column [10, 11]. This approach can 
increase blood flow in the foot as well as reduce ischemic pain in the hands and feet following 
SCS treatment [10]. It has been hypothesized that SCS deactivates sympathetic tone and thus 
decreases pain and increases blood flow [12, 13]. The deactivation of the sympathetic nervous 
system reduces pain by the inhibition of nocioceptors, thus interrupting the pain signal. Although 
SCS appears to be a promising treatment for PAD (reducing pain and increasing blood flow), 
there are some limitations. This treatment requires a skilled physician or surgeon to implant the 
SCS system, and is not ideal for our research because it involves performing a surgery on healthy 
college-aged students, which would be above our capabilities.  
A less invasive method of neurostimulation is electroaccupuncture. Electroacupuncture is 
performed similarly to acupuncture; needles are inserted at specific acupoints on the body, which 
will give a desired effect, but the needles in this case are attached to electrodes. Acupuncture has 
been historically used for pain management, so it could be potentially used to treat ischemic 
pain.  Its cardiovascular effects have been researched in many animal models, but less so in 
humans. Depending on the location of the treatment, electroaccupuncture can increase blood 
flow in areas of ischemia [14]. In addition, electroaccupuncture may cause the release of 
endogenous opioids and monoamines to mitigate pain and NO to dilate vessels [15].  This 
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method of neurostimulation appears to be promising, but it requires a licensed acupuncturist to 
properly place the needles/electrodes.  
Two non-invasive methods of stimulation are IFC and TENS. IFC is thought to function by 
causing deeper stimulation to the tissue, therefore affecting a greater number of afferent neurons. 
It uses a biphasic pulse which is modulated between 4100 Hz and 4000 Hz, creating a unique 
current illustrated in Figure 3. The interference between the two frequencies creates a modulated 
frequency of 100 Hz applied to the tissue [16]. The crisscrossed electrodes allow for the currents 
to travel through the length of the tissue, penetrating the tissue further and thus stimulating more 
neurons. TENS on the other hand produces a current that travels horizontally and provides more 
of a superficial stimulation. TENS also produces a biphasic current and functions by stimulating 
the afferent neurons, similar to the current seen in channels 1 or 2 of Figure 3. Interestingly, 
these two methods of stimulation may relieve pain through differing mechanisms [16]. These 
two types of stimulation will be investigated in this study because they are non-invasive and 
have been proven effective at reducing ischemic pain and improving blood flow in other studies.  
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Figure 3. An illustration of the modulated frequency produced by IFC. The 
interference in Channels 1 and 2 produces a modulated frequency depicted in the AMF 
chart [16]. 
 
1.3 Mechanism 
 
There are several hypotheses to explain how pain signals are received and sent throughout the 
body. The most widely supported is the gate control theory. The gate control theory was first 
hypothesized in 1965 and stated that small neuron fibers, C fibers, transmit pain signals while 
large diameter fibers, labelled Aβ, transmit tactile sensations. The gate control theory suggests 
that only one of these types of fibers can transmit signals while the other is inhibited by a gate. 
As seen in Figure 4, these fibers transmit nociceptive information via action potentials to 
projection cells (SG) which are transmitted to the brain or inhibitory neurons in the spinal cord 
[17].  
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Figure 4. The gate control theory. Large and small diameter fibers cannot 
transmit signals at the same time to projection cells in the spinal cord. This is 
possible through the gate system illustrated in this figure [17]. 
 
In addition to the gate control theory, the metaboreflex may be activated during ischemic 
conditions. The metaboreflex is triggered by cardiovascular exercise or ischemic byproducts 
such as lactic acid, which stimulate the small afferent fibers to increase sympathetic output [18]. 
The increased sympathetic output increases heart rate and causes vasoconstriction to elevate 
blood pressure. In healthy individuals, this reflex occurs to improve oxygen delivery during 
exercise, but in individuals experiencing ischemia, this reflex is constantly activated. Therefore, 
there is reduced waste removal from these active cells and no functional sympatholysis. This 
causes increased sympathetic output, seen in increased catecholamine levels, which cause 
increased heart rate and vasoconstriction.  
In order to evaluate this proposed mechanism of the metaboreflex, we measured heart rate, 
systolic (SBP) and diastolic (DBP) blood pressures, perfusion, and ischemic pain, and calculated 
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vascular resistance (CVR) and mean arterial pressure, while activating the metaboreflex and 
inducing ischemia. We hypothesize that application of TENS or IFC at the dermatome C7 and 
T4 on the back, or the application of TENS or IFC on the forearm will decrease sympathetic 
activity.  The C7 dermatome innervates the arms and the T4 innervates the heart. The decrease in 
sympathetic output will be demonstrated by increased blood perfusion, decreased heart rate, 
decreased vascular resistance, and decreased blood pressure and MAP in induced-ischemic 
individuals compared to healthy individuals. Additionally, we hypothesize that a decrease in 
sympathetic activity will occur in individuals who receive TENS or IFC compared to no 
treatment (control) as indicated in Table I when experiencing post-exercise circulatory occlusion 
(PECO).  
Table I – Expected Outcomes from the Application of TENS in the Pilot Study 
 Placebo TENS 
Expected Outcome PECO- PECO+ PECO- PECO+ 
Heart Rate ↓ - ↓ - 
Blood Pressure ↓ - ↓ ↓↓ 
Blood Flow ↓ - ↑ ↑↑ 
Vascular Resistance ↓ - ↓ ↓↓ 
Mean Arterial 
Pressure 
↓ - ↓ ↓↓ 
Ischemic Pain - - - ↓↓ 
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CHAPTER 2: METHODS OF PRE-PILOT WORK 
2.1 Test Subjects 
Two healthy college students, both 23 years old, were observed in this study. They had no 
known illnesses. 
2.2 Experimental Design 
 
To investigate the effects IFC and TENS on blood perfusion and ischemic pain during induced 
ischemia, we evaluated varying frequencies and locations of stimulation, based on parameters 
from previous studies [19, 20, 21]. The modalities investigated were TENS at 100 Hz and 4 Hz, 
and IFC at 100 Hz applied to the forearm or the back. Table II indicates the optimized 
treatment settings used in this study. Each individual completed the control and treatment 
protocols approximately every other day, performing the control protocol first with a 30-minute 
break in between testing periods to prevent residual effects of neurostimulation.  
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Table II – Treatment Parameters for TENS and IFC Testing 
 
Treatment 
Method 
Frequency (Hz) Pulse Width 
(µs) 
Treatment 
Duration (min) 
Intensity 
Range (mA) 
 
TENS Back– High   
Frequency 
 
 
100 
 
200 
 
15 
 
12-13 
TENS Forearm – 
High Frequency 
 
100 200 15 6-8 
TENS Back – Low 
Frequency 
 
4 200 15 11-14 
TENS Forearm – 
Low Frequency 
 
4 200 15 6-8 
IFC Back  
 
100 (modulated) 200 15 7-11 
IFC Forearm 
 
100 (modulated) 200 15 5 
 
A data acquisition system (Powerlab 26T, ADInstrument) and digital recording software 
(LabChart 7 Pro, ADInstruments) were used to collect blood perfusion data. Appendix A details 
the measurement tools used to collect respiration, grip force, and blood perfusion information 
through the data acquisition system.  
2.3 Protocol 
 
Blood perfusion, blood pressure, and heart rate were measured using a laser Doppler system 
(VMS-LDF2, Moor Instruments) and an automated sphygmomanometer (Life Source, Model 
#UA-767 Plus) under similar conditions described in previous studies [22]. Figure 5 illustrates 
the configuration of the testing equipment. Briefly, the volunteer sat up straight in the chair with 
their forearms resting on the table in a supine position, and for more comfort and fewer motion 
artifacts, a pillow was available for the forearms to rest on. Next, the manual 
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sphygmomanometer (CVS, Model #BPAG1-20CVS) was placed the left forearm, about 3 inches 
distal to the elbow. The automated sphygmomanometer was placed on the upper right arm. The 
laser Doppler probes were attached on the lower surface of the palm, 2 cm distal from the wrist 
or just proximal to the antecubital fossa. Finally, the neurostimulation (inTENSity Select 
Combo) probes were placed on the C7 and T4 dermatomes indicated in Figure 6A, or the 
forearm, Figure 6B.  
 
Figure 5. Experimental set-up for pre-pilot work. A) Manual blood 
pressure cuff B) Hand dynamometer C) Digital blood pressure cuff D) 
Respiration belt E) LDF system F) PowerLab system G) Blood pressure 
monitor H) Stimulator I) Laptop with LabChart software.  
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Figure 6. The placement of neurostimulation electrodes. (A) Location of electrode placement 
on the back, C7 and T4 dermatomes. (B) Electrode placement for neurostimulation on the 
forearm for IFC, for TENS probes placed with Channel 1 having both probes proximal and with 
Channel 2 both probes distal, with the polarities the same located on the same side between 
channels [21].  
 
Once the individual was properly instrumented, they performed hand-grip contractions using the 
hand dynamometer for 3 repetitions of 2 seconds each, which were averaged to determine the 
maximum voluntary contraction. Twenty-five percent of the max contraction force was 
calculated. Next the individual experienced 3 minutes each of pre-stimulation, baseline, exercise, 
occlusion, and recovery, Figure 7. Pre-stimulation occurred before all other steps, and during 
pre-stimulation, the individual only received the neurostimulation; no measurements were taken. 
Skin temperature was recorded at the beginning of testing via the Moor skin probes. Blood 
pressure was measured at the middle of the baseline, exercise, occlusion, and recovery portions, 
followed by the ischemic pain level. Ischemic pain was measured via the Numerical Rating Scale 
(NRS).  
A B 
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Figure 7. A visual progression of the steps performed in testing procedure. The arrow indicates at 
what time during that phase the measurement was taken. If running a control experiment, no stimulation 
was administered starting at the beginning of the pre-stimulation step. Each step had a fixed duration of 3 
minutes.  
 
During pre-stimulation, the individual began receiving neurostimulation and the intensity of the 
stimulation was set to just below the motor threshold and also to an intensity that did not cause 
discomfort. During control testing, pre-stimulation was simulated but not administered. During 
pre-stimulation and baseline, the individual sat still and did not talk, but at the beginning of 
exercise, the individual applied 25% of his/her maximum contraction force to the hand grip 
dynamometer for 3 minutes. After 3 minutes of exercise, the dynamometer was removed from 
the hand and the manual sphygmomanometer was inflated to 180 mmHg to induce ischemia for 
3 minutes. The sphygmomanometer was deflated to allow reactive hyperemia and recovery. 
During this pre-pilot work, control data was recorded first, followed by the treatment; a 
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representative data trace can be seen in Figure 8. To normalize the data and reduce individual 
variation, the data was presented as the percent changes from baseline. Two-way ANOVA 
followed by Tukey post hoc test analyses were performed. 
 
 
 
 
 
 
 
 
 
Figure 8. A representative data trace acquired during testing. The top red line corresponds to 
breathing in mV, the light blue line is breathing rate in breaths per minute (BPM), the green line is grip 
force in N, The pink line is distal blood perfusion, and the blue line is proximal blood perfusion. The trace 
is showing a time of occlusion (minimal distal blood flow).  
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CHAPTER 3: RESULTS 
3.1 TENS at 100 Hz on the Back 
 
To test the hypothesis that neurostimulation will improve blood perfusion in healthy individuals 
with induced ischemia, high frequency TENS was applied to the back, but there were no 
significant changes compared to control, Figure 9. However, the palm perfusion tended to 
increase during recovery while the brachial perfusion remained stable during all phases. The SBP 
tended to increase, while the DBP deviated from the results seen in the control. Heart rate 
showed an inverse pattern from the control, while the MAP in the treatment varied due to the 
inconsistent blood pressure results. The CVR in the palm tended to decrease in the treatment and 
increase in the brachial region compared to control.  
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Figure 9. Hemodynamic responses to TENS application on the back at 100 Hz (Treatment) as 
compared to Control. Treatment in light gray compared to control in dark gray. A) Blood flow in the left 
palm; B) Blood flow in the left anterior brachial region; C) Systolic blood pressure D) Diastolic blood 
pressure E) Heart rate F) Mean arterial pressure G) Cutaneous vascular resistance in the palm; H) 
Cutaneous vascular resistance in the anterior brachial region. 
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3.2 TENS at 100 Hz on the Forearm 
The next neurostimulation tested was high frequency TENS applied to the forearm. There were 
not any significant differences found, but some similar trends to TENS on the back at 100 Hz 
were observed, Figure 10. These similar trends included increased palm and brachial perfusion 
and decreased vascular resistance compared to control. Heart rate was higher in this treatment 
than control. Like TENS at 100 Hz on the back, the treatment palm CVR was lower, but the 
brachial CVR was also lower all compared to control.  
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Figure 10. Hemodynamic responses to TENS application on the forearm at 100 Hz (Treatment) as 
compared to control. Treatment is light gray and control is dark gray. A) Blood flow in the left palm; B) 
Blood flow in the left anterior brachial region; C) Systolic blood pressure D) Diastolic blood pressure E) 
Heart rate F) Mean arterial pressure G) Cutaneous vascular resistance in the palm; H) Cutaneous vascular 
resistance in the anterior brachial region.  
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3.3 TENS at 4 Hz on the Back 
 
 
When low frequency TENS was applied to the back, no significant changes between control and 
treatment groups were observed, Figure 11. With this specific treatment, perfusion on the palm 
as well as in the brachial region tended to increase compared to control, meaning there was 
improved blood flow. Like the previous treatment groups, a correlation between SBP, DBP, and 
MAP could not be made. Heart rate also did not appear to have a noticeable trend. The palm and 
brachial CVRs were both lower than the control.  
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Figure 11. Hemodynamic responses to TENS application on the back at 4 Hz (Treatment) as 
compared to control. Treatment is in light gray, control in dark gray. A) Blood flow in the left palm; B) 
Blood flow in the left anterior brachial region; C) Systolic blood pressure D) Diastolic blood pressure E) 
Heart rate F) Mean arterial pressure G) Cutaneous vascular resistance in the palm; H) Cutaneous vascular 
resistance in the anterior brachial region.  
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3.4 TENS at 4 Hz on the Forearm 
 
Investigating low frequency TENS on the forearm did not present any significant differences 
from control data, Figure 12. The palm perfusion was again very similar to control data, while 
brachial perfusion was tended to increase in the treatment group. The treatment presented lower 
SBP, while the DBP was very similar to control. For this reason, the MAP decreased more than 
the control. The heart rate remained lower in the treatment group than control as well as brachial 
CVR, while palm CVR was almost indistinguishable from the control.  
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Figure 12. Hemodynamic responses to TENS application on the forearm at 4 Hz (Treatment) as 
compared to control. Treatment is represented in light gray, control in dark gray. A) Blood flow in the 
left palm; B) Blood flow in the left anterior brachial region; C) Systolic blood pressure D) Diastolic blood 
pressure E) Heart rate F) Mean arterial pressure G) Cutaneous vascular resistance in the palm; H) 
Cutaneous vascular resistance in the anterior brachial region. 
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3.5 IFC on the Back  
 
 
After all the combination of frequencies and stimulation locations for TENS were investigated, 
the application of IFC on the back was compared to control, Figure 13. There were no 
significant differences, but the palm perfusion tended to decrease compared to control. No trend 
could be seen in brachial perfusion, and similarly there was no trend seen in SBP, MAP, or 
brachial CVR. DBP was very similar to control data, and HR in the treatment was higher than 
control. CVR in the palm was lower than control which has been seen in several other treatment 
groups. 
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Figure 13. Hemodynamic responses to IFC application on the back (Treatment) as compared to 
control. Treatment is represented in light gray and control in dark gray. A) Blood flow in the left palm; 
B) Blood flow in the left anterior brachial region; C) Systolic blood pressure D) Diastolic blood pressure 
E) Heart rate F) Mean arterial pressure G) Cutaneous vascular resistance in the palm; H) Cutaneous 
vascular resistance in the anterior brachial region.  
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3.6 IFC on the Forearm 
 
The results from comparing the percent change in IFC applied to the forearm to control are 
displayed in Figure 14. There were no significant differences between the treatment and the 
control. For this treatment, the percent change in palm perfusion, heart rate, and CVR in the palm 
are virtually identical to the control data.  Perfusion in the brachial region tended to decrease 
compared to the control. No correlation could be made for the SBP, and for all the other 
measured parameters, the treatment had lower values than control (DBP, MAP, and brachial 
CVR).  
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Figure 14. Hemodynamic responses to IFC application on the forearm (Treatment) as compared to 
control. Treatment is represented in light gray, control in dark gray. A) Blood flow in the left palm; B) 
Blood flow in the left anterior brachial region; C) Systolic blood pressure D) Diastolic blood pressure E) 
Heart rate F) Mean arterial pressure G) Cutaneous vascular resistance in the palm; H) Cutaneous vascular 
resistance in the anterior brachial region.  
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3.7 Combined Data Analysis 
 
 
The percent changes from baseline were compiled for each testing parameter, blood perfusion, 
heart rate, blood pressure, etc., to more effectively compare the impact of each type of 
stimulation compared to control; error bars were excluded from these plots for enhanced figure 
visualization. The first parameter compared was palm blood perfusion, Figure 15. It was 
expected that the application of neurostimulation would increase this compared to the control. In 
this figure, control data was represented with the blue line. There were no significant changes 
observed, but there was a trend for increased perfusion in exercise, decreased in occlusion, and a 
large increase in recovery.  
 
Figure 15. The percent change in palm blood perfusion in each treatment 
method and control. The percent change in palm blood perfusion in each treatment 
method and control TENS at 4 Hz on the back had the greatest increase in perfusion, 
while all others showed improved perfusion over the control except for IFC on the 
back. 
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The next parameter investigated was brachial blood perfusion, Figure 16. Brachial perfusion was 
expected to increase with the application of neurostimulation during all testing phases compared 
to control. Through testing, the trend of the data confirmed this except in IFC on the back and 
high frequency TENS on the back. 
 
Figure 16. Percent change in brachial blood perfusion for each treatment 
method. All treatments experienced improved perfusion compared to the control, the 
highest of which was TENS on the arm at 100 Hz, excluding IFC on the back and 
TENS on the back at 100 Hz.  
 
Another important indicator of vasodilation is blood pressure. SBP changes were compared 
between all treatment groups in Figure 17. It was observed that the SBP generally increased 
during exercise, decreased during occlusion, and increased during recovery. It was predicted that 
there would be a decrease in systolic blood pressure compared to control, but the mixed results 
are not able to justify this hypothesis.  
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Figure 17. Percent change in SBP based on treatment method. Varying trends in the results 
were observed, with treatments presenting different changes in SBP depending on the testing 
step. For example, TENS on the back at 4 Hz has a v-shaped response, while the control group 
almost has a linear change. TENS on the back at 100 Hz presented a similar pattern to the 
control group and had a higher percent change. TENS on the arm at 4 Hz however the greatest 
decrease in SBP compared to control. 
 
The DBP showed similarly inconclusive data, Figure 18. It was expected that DBP would also 
decrease during all testing phases compared to control with the application of neurostimulation, 
but this could not be confirmed.  
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Figure 18. Percent change in DBP based on the treatment method. Differing patterns 
based on the treatment parameters were observed. IFC on the arm had a much lower percent 
change in DBP compared to the other treatments. TENS on the back at 4 Hz, displayed an 
unusual pattern, similar to the pattern it presented in SBP.  
 
MAP was calculated using SBP and DBP to give an estimation of the pressure experienced in the 
vessels. There were no differences between the treatments’ effect on MAP, but there was a trend 
showing an increase during occlusion, which was expected, Figure 19. It was expected that 
MAP would be decrease with the application of neurostimulation compared to the control.  
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Figure 19. Changes in MAP based on the treatment method. IFC on the back as well as 
TENS at 100 Hz on the back increased MAP, while the greatest decrease in MAP was 
witnessed in IFC on the arm. *Note: approximated MAP 
 
Heart rate, which was measured at the same time as blood pressure, showed differing patterns as 
well based on the treatment, Figure 20. There were no differences between any of the 
treatments, and there was no identifiable trend. We were not expecting to find any differences 
from control.  
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Figure 20. Percent change in heart rate due to treatment method. IFC on the arm had very 
similar percent changes to control, while the majority of the treatments showed a different 
pattern from the control. Of all the treatment methods, IFC on the back had the highest increase 
compared to control. 
 
CVR in the palm was compared between all the treatment methods, Figure 21. CVR was 
expected to decrease, and it tended to increase during occlusion and decrease again during 
recovery. All treatments the followed a characteristic trend; however, IFC on the arm actually 
performed worse than the control. This means that there was more resistance in the vessels, 
making it harder for blood to flow to the desired region.  
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Figure 21. Changes to CVR in the palm region due to treatment method. IFC on the back 
had the greatest decrease in CVR, indicating it allowed the most blood flow compared to all 
other treatments. IFC on the arm had the greatest increase over control, indicating more 
resistance to flow.  
 
CVR in the brachial region yielded mixed results due to the variability of the perfusion readings, 
Figure 22. There were no significant differences, but there was a trend for decreased CVR 
during occlusion which increased again during recovery. CVR was not expected to differ from 
the control.  
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Figure 22. Changes to CVR in the brachial region due to treatment conditions. It was 
observed that brachial flow increased the most on average for TENS on the back at 100 Hz. IFC 
on the back also had higher than control results which then became lower during recovery. The 
other treatments caused lower percent changes in brachial blood flow compared to control, the 
lowest of which on average was TENS on the arm at 100 Hz.  
 
Ischemic pain, which was measured using the NRS on a scale from 0-10, showed no differences 
in any treatment, but there was a trend indicating increased ischemic pain during exercise which 
was further amplified during occlusion, and decreased again during recovery as blood flow 
normalized, Figure 23. A pain rating of 0 indicated no pain, while 10 indicated the worst pain 
possible.  
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Figure 23. Change in ischemic pain levels correspond to treatment method.The lowest 
ratings were observed during IFC on the back. Both TENS on the back at 4 Hz and TENS on 
the arm at 100 Hz had higher pain ratings than the control. 
 
Reperfusion time, or the time to recovery, was obtained by measuring the amount of time 
necessary for the blood perfusion to stabilize back to the baseline average during the recovery 
phase. There was a significant decrease in IFC on the back compared to all other treatment 
methods, Figure 24 (p<0.05).  
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Figure 24. Average time to full recovery. IFC on the back had a statistically significantly 
reperfusion time. TENS on the back at 4 Hz had a slightly longer reperfusion time than 
control. * p-value < 0.05 compared to control.  
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CHAPTER 4: DISCUSSION 
PAD is a painful disease caused by limited blood flow to the extremities. Many treatments used 
for this disease have side effects, but neurostimulation has been investigated for its ability to 
modulate pain and improve blood flow, especially in individuals with ischemic pain. The 
purpose of this study was to determine the ideal treatment for a future pilot study to increase 
perfusion and reduce ischemic pain. Once the ideal parameters have been determined, a full pilot 
study will be conducted to investigate the effect of the neurostimulation. To determine the best 
treatment, we measured perfusion in the palm, SBP, MAP, CVR in the palm region, ischemic 
pain, and reperfusion time based on the neurostimulation’s inhibitory effect on the metaboreflex. 
The inhibition of the metaboreflex decreases sympathetic output. Although there were no 
significant changes from control in any of the treatments, almost all treatment groups 
demonstrated a trend towards increased perfusion. This suggests that TENS and IFC have the 
potential to reverse ischemia by increasing perfusion. MAP also had varying data because it was 
calculated from a static measurement, but IFC on the arm presented the greatest decreasing trend. 
All treatment groups expressed a decrease in CVR excluding TENS on the arm at 100 Hz; 
however, IFC on the back showed the greatest decrease. In addition, IFC on the back had the 
lowest reported ischemic pain and had a significant reduction in reperfusion time (p<0.05). From 
this data it is not possible to make a clear decision as to which treatment is the best for pilot 
work. IFC presented some positive pre-pilot results, though more pre-pilot work will need to be 
performed. In order to determine the ideal treatment method, all treatment modalities which 
performed better than control should be analyzed with a larger sample size. 
Previous work using TENS and IFC to modulate pain and increase perfusion in individuals with 
ischemia has found some significant results, Table III. Several studies have concluded that low 
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frequency TENS significantly increases perfusion when applied to the arm compared to high 
frequency TENS and control [20, 24]. Based on the research performed in this current study, low 
frequency TENS applied to both the back and forearm had a trend towards increased palm 
perfusion compared to the control group. In addition, the increasing trend in blood flow for 
TENS at 100 Hz high frequency TENS was statistically similar to low frequency. An article 
expanded on the parameters tested, including MAP and CVR, while studying high intensity 
TENS. They found that there was increased blood flow when high frequency TENS was applied 
compared to the control as well as lower CVR, and a similar trend was found in this study [22]. 
IFCs effect on blood flow and ischemic pain has also been previously investigated [16, 21]. In 
this research, high frequency IFC produced the greatest increase and blood flow [21]. Although 
we were not comparing different IFC frequencies in this current study, we were able to see that 
IFC had lower MAPs and CVRs than control. These parameters can be correlated to blood flow. 
One article compared the use of high frequency TENS versus high frequency IFC, and found that 
both TENS and IFC caused significantly less ischemic pain during induced ischemia in healthy 
patients [16]. Interestingly, IFC and TENS at 100 Hz applied to the back tended to reduce 
ischemic pain while TENS at 100 Hz applied to the forearm tended to increase ischemic pain. 
One explanation for this is that the blood pressure cuff used to induce ischemia overlapped with 
the electrodes. TENS at 100 Hz creates a strong tingling feeling when applied to the forearm, and 
when the cuff was inflated it compressed the electrodes, which could have caused increased 
nocioception.  
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Table III – A Summary of Previous Study Results 
Article Measurement 
Information 
Study 
Parameters 
Measurements Number of 
Subjects 
Results 
 
Cramp et al. 
2002 [24] 
 
 
Brachial and finger, 
healthy individuals  
 
TENS 4 Hz 
 
Blood flow 
 
40 
 
Significant 
increase from 
control 
 
Cramp et al. 
2000 [20] 
 
Forearm, healthy 
subjects 
TENS 4 Hz, 110 
Hz 
Blood flow 30 4 Hz showed 
significant 
increase 
 
Vieira et al 
2011 [22] 
Calf, healthy 
subjects 
TENS 80 Hz Blood flow, MAP, 
CVR 
22 TENS – higher 
blood flow, 
lower CVR, 
higher MAP 
during exercise 
 
Noble et al. 
2000 [21] 
Quadriceps femoris, 
healthy subjects 
IFC 80-100 Hz, 
10-20 Hz 
Blood flow 50 Higher 
frequency 
produced 
significant 
change 
 
Johnson et al. 
2003 [16] 
Forearm, healthy 
subjects 
IFC 100 Hz, 
TENS 100 Hz 
Pain intensity 30 TENS, IFC had 
less pain 
 
There were some limitations and possible causes for error during this research, including 
environmental factors such as cold temperature causing vasoconstriction and warm causing 
vasodilation. The effect of temperature was not analyzed in this data, and if body temperature 
changed during the testing, it could have inappropriately biased the results. In future testing, skin 
temperature will be measured at the beginning of each testing phase to ensure the effect of skin 
temperature is accounted for. Another problem was biofeedback; knowing how each of our 
hemodynamic parameters was supposed to change, could have inadvertently altered the results. 
Biofeedback can be reduced by inhibiting the individual’s visual access to the testing results. A 
major limitation in this study was the small sample size (n=2). With such a small sample size, we 
did not have sufficient power to detect changes in our measured parameters. Similar studies 
tested between 22 and 50 individuals, but we were limited to testing on ourselves for pre-pilot 
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purposes. Ensuring individual comfort was also a challenge, particularly because any slight 
movement altered the readings on the laser Doppler system due to its sensitivity. Any motion 
artifacts seen in the raw data were removed from the trace to prevent false information. 
Discomfort could lead to artificially high hemodynamic parameters such as blood pressure and 
breathing. Through this study, it was determined that heavy breathing, over 50 mV strain on the 
ventilator belt, or irregular breathing patterns affected perfusion readings. Measures were taken 
to improve comfort such as a pillow, but sitting for long periods of time without moving can be 
difficult. Therefore, in future work a recumbent setup should be tested to see if it will reduce 
movement as well as how it affects blood flow. In addition to comfort, there were many factors 
that could affect the individual’s results including lack of sleep, prior exercise, stress, and the 
consumption of stimulants such as caffeine and nicotine. These factors increase sympathetic 
output and could decrease the effectiveness of the treatment. The lack of continuous blood 
pressure measurement led to varied blood pressure results, making it harder to make conclusions 
about these treatments. Perhaps a continuous-measurement-system could be acquired for future 
research.  
Other future work will include an investigation into the duration of the residual effects of the 
neurostimulation and investigating the systemic effects. Once additional pre-pilot work has been 
conducted, a full pilot study will be performed using the testing groups in Table I. Healthy 
students will be recruited and additional effects will be investigated such as skin temperature and 
sex.  
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CONCLUSION 
TENS and IFC tend to have a favorable effect on hemodynamics and ischemic pain. IFC 
appeared to be the most effective neurostimulation modality, but it was not possible to make a 
conclusion as to which treatment method was able to produce the best results due to the need for 
additional replicates. Additional pre-pilot work will be continued to investigate this.  
Once the pre-pilot work is completed, a pilot study followed by a full study will be conducted. 
The pilot study will use healthy college-aged students to investigate the effects of the selected 
neurostimulation modality on perfusion and ischemic pain, utilizing the 4 testing groups 
indicated in Table I. The pilot study will be the basis for a full research study investigating the 
effectiveness of the neurostimulation on individuals with PAD and ischemic pain. It is the hope 
that this will become a treatment used to alleviate the symptoms of PAD and improve quality of 
life.  
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APPENDICES 
Appendix A – Data Collection Systems 
 
First the Powerlab system was configured and a custom settings file was created using four 
channels for: 1. Respiration Belt (Pneumotrace II Model #MLT1132/D), 2. Hand Dynamometer, 
3. Distal Blood Perfusion and 4. Proximal Blood Perfusion. Blood perfusion was measured using 
the VMS-LDF2 Laser Doppler System and VP1T/7 skin probes (Moor Instruments). The readout 
of the Moor system was inspected to ensure perfusion measurements were being taken. Next, the 
volunteer was prepared for testing. 
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Appendix B – Average Values of All Parameters  
 
 Exercise Occlusion Recovery 
Control (n = 20)    
CBF 1 20.61408 -90.1396 70.7512 
CBF 2 6.181795 10.56105 -7.52406 
SBP 4.922132 2.513589 1.065731 
DBP 4.045545 4.212532 2.391328 
HR 4.116884 4.732632 -0.72447 
MAP 4.343151 3.420077 1.658637 
CVR 1 1.979512 1258.739 -36.7768 
CVR 2 -1.34234 -3.54692 12.89023 
*
TENS Application 
on the Back at High 
Frequency (n = 6) 
   
CBF 1 25.43661 -81.5803 185.0897 
CBF 2 -5.5738 -12.4239 -8.40812 
SBP 6.04962 5.324572 5.120653 
DBP 0.036075 5.411255 -0.03608 
HR 2.698413 -2.43386 2.195767 
MAP 2.595939 5.37299 2.147184 
CVR 1 -18.2172 570.4271 -54.2402 
CVR 2 11.68384 21.19491 13.07613 
*
TENS Application 
on the Forearm at 
High Frequency (n 
= 2) 
   
CBF 1 16.45631 -80.0942 114.3978 
CBF 2 17.8305 24.17139 2.384457 
SBP 0.81187 2.874207 -4.04069 
DBP 3.159981 5.538713 0.034981 
HR 8.249337 6.618037 2.122016 
MAP 2.145089 4.337402 -1.7909 
CVR 1 -5.08757 597.8964 -45.3314 
CVR 2 -12.8027 -13.8696 -3.84971 
*
TENS Application 
on the Back at Low 
Frequency (n = 2) 
   
CBF 1 84.16821 -77.4402 259.6295 
CBF 2 14.21466 14.37029 4.612285 
SBP 10.29571 -3.0833 0.531915 
DBP 9.732163 2.34357 2.574463 
HR 9.254386 2.675439 5.921053 
MAP 9.975071 -0.03917 1.698718 
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CVR 1 -10.7307 802.1998 -52.9969 
CVR 2 -3.47213 -10.4482 -2.73357 
TENS Application 
on the Forearm at 
Low Frequency (n 
= 2) 
   
CBF 1 44.57743 -82.7889 72.09013 
CBF 2 5.046217 19.99818 -6.70987 
SBP 0.423812 -5.45535 -1.87759 
DBP 6.737288 4.265537 3.418079 
HR 4.312039 5.454545 -5.42998 
MAP 3.67893 -0.19509 1.161278 
CVR 1 -16.3281 1184.719 -34.5453 
CVR 2 0.07898 -16.9482 9.427779 
*
IFC Application 
on the Back (n = 2) 
   
CBF 1 -15.2391 -80.6055 3.330334 
CBF 2 1.131429 -1.04201 -0.52675 
SBP -1.40911 6.140351 -0.90519 
DBP 6.299841 5.023923 2.232855 
HR 13.95161 8.225806 8.252688 
MAP 2.753674 5.581614 0.869684 
CVR 1 25.3756 445.1115 0.364934 
CVR 2 1.982277 6.688098 2.013535 
*
IFC Application 
on the Forearm (n = 
4) 
   
CBF 1 68.73909 -89.7606 117.8071 
CBF 2 20.54841 37.41265 5.370384 
SBP 3.632479 6.452991 3.076923 
DBP -4.3794 1.947623 -2.26673 
HR 2.255727 8.625526 -1.6129 
MAP -0.92894 4.044313 0 
CVR 1 -10.8726 1518.964 -43.7508 
CVR 2 -16.7931 -20.5259 -2.40704 
 
 
 
 
 
 
